Predict your next investment

Venture Capital
lyzzcap.com

See what CB Insights has to offer

Investments

27

Portfolio Exits

2

Funds

1

About LYZZ Capital

LYZZ Capital is a China-based healthcare, growth, and M&A fund.

LYZZ Capital Headquarter Location

Room A1103, Tower A, SOHO Fuxing Plaza 388 Ma Dang Road, Huang Pu District

Shanghai, Shanghai,

China

+86 021 61209595

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing LYZZ Capital

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find LYZZ Capital in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

Latest LYZZ Capital News

Wugen Raises $172M in Series B Funding

Jul 17, 2021

Wugen , a Sant Louis MO- and San Diego CA-based clinical stage biotechnology company, raised $172M in Series B funding. The round was led by Abingworth and Tybourne Capital Management with participation from Fidelity Management & Research Company, Intermediate Capital Group (ICG), Sands Capital, Aisling Capital Management, Alexandria Venture Investments, Velosity Capital, Falcon Edge Capital, RiverVest Venture Partners, LYZZ Capital, Lightchain Capital. The company intends to use the funds to support the clinical development of its memory natural killer (NK) cell platform and advance ongoing trials for patients with severe acute myelogenous leukemia (AML) and other oncology indications, as well as to advance its broader pipeline of next-generation products into the clinic. Led by Dan Kemp, Wugen provides a clinical-stage biotechnology company developing a pipeline of off-the-shelf memory natural killer (NK) cell therapies to treat a broad range of hematological and solid tumor malignancies. In addition, the company is developing a pipeline of programs targeting solid tumor indications. FinSMEs 17/07/2021

LYZZ Capital Investments

27 Investments

LYZZ Capital has made 27 investments. Their latest investment was in Wugen as part of their Series B on July 7, 2021.

CBI Logo

LYZZ Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

7/15/2021

Series B

Wugen

$172M

No

6

6/10/2021

Series A

Onchilles Pharma

$7M

Yes

2

6/9/2021

Series B

Qingyun Technology

No

4

6/8/2021

Series A - II

Subscribe to see more

$99M

Subscribe to see more

10

3/29/2021

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/15/2021

6/10/2021

6/9/2021

6/8/2021

3/29/2021

Round

Series B

Series A

Series B

Series A - II

Seed VC

Company

Wugen

Onchilles Pharma

Qingyun Technology

Subscribe to see more

Subscribe to see more

Amount

$172M

$7M

$99M

$99M

New?

No

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

6

2

4

10

10

LYZZ Capital Portfolio Exits

2 Portfolio Exits

LYZZ Capital has 2 portfolio exits. Their latest portfolio exit was Microtech Medical on October 19, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

10/19/2021

IPO

$991

3

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

Date

10/19/2021

00/00/0000

Exit

IPO

Subscribe to see more

Companies

Subscribe to see more

Valuation

$991

$991

Acquirer

Subscribe to see more

Sources

3

10

LYZZ Capital Fund History

1 Fund History

LYZZ Capital has 1 fund, including Jiangsu Jiequan Lyzz Healthcare Venture Capital Fund.

Closing Date

Fund

Fund Type

Status

Amount

Sources

Jiangsu Jiequan Lyzz Healthcare Venture Capital Fund

Multi-Stage Venture Capital

1

Closing Date

Fund

Jiangsu Jiequan Lyzz Healthcare Venture Capital Fund

Fund Type

Multi-Stage Venture Capital

Status

Amount

Sources

1

LYZZ Capital Team

1 Team Member

LYZZ Capital has 1 team member, including current Managing Partner, Kevin Li.

Name

Work History

Title

Status

Kevin Li

Toucan Capital

Managing Partner

Current

Name

Kevin Li

Work History

Toucan Capital

Title

Managing Partner

Status

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.